APA (7th ed.) Citation

Yan, J., Wu, J., Wang, R., Meng, P., Liu, A., & Xu, Y. The systemic immune-inflammation index is superior to predicting clinical remission and relapse for ulcerative colitis patients treated with vedolizumab. Frontiers Media S.A.

Chicago Style (17th ed.) Citation

Yan, Jing, Jun Wu, Rongkun Wang, Pin Meng, Ailing Liu, and Yonghong Xu. The Systemic Immune-inflammation Index Is Superior to Predicting Clinical Remission and Relapse for Ulcerative Colitis Patients Treated with Vedolizumab. Frontiers Media S.A.

MLA (9th ed.) Citation

Yan, Jing, et al. The Systemic Immune-inflammation Index Is Superior to Predicting Clinical Remission and Relapse for Ulcerative Colitis Patients Treated with Vedolizumab. Frontiers Media S.A.